Form 4: Marvell Technology COO Chris Koopmans Reports Significant RSU Vesting and New Grant

Marvell Technology, Inc.'s President and COO, Chris Koopmans, reported the vesting of restricted stock units and a new RSU grant, alongside associated tax withholdings, as part of pre-planned transactions.

Summary

• Chris Koopmans, President and COO of Marvell Technology, Inc. (MRVL), reported multiple transactions on July 15, 2025, related to his equity holdings.
• A total of 11,360 common shares were acquired through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.00.
• Concurrently, 5,633 common shares were disposed of at a price of $72.41 per share to cover tax withholding obligations arising from the RSU vesting.
• Following these transactions, Koopmans' indirect beneficial ownership through a family trust stands at 98,025 common shares.
• Additionally, Koopmans directly holds 44,847 vested Restricted Stock Units and received a new grant of 112,560 Restricted Stock Units.
• Total holdings also include 233 shares purchased on June 6, 2025, under the company's Employee Stock Purchase Plan (ESPP).

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects routine executive compensation, including significant RSU vesting and a new grant, which aligns management's interests with long-term company performance. The share disposition is for tax purposes, a standard and expected event.

Positives

• The vesting of 11,360 Restricted Stock Units at a $0.00 exercise price represents a significant increase in the executive's direct share ownership.
• A new grant of 112,560 Restricted Stock Units aligns the executive's long-term incentives with shareholder value creation.
• The transactions were made pursuant to a Rule 10b5-1 plan, indicating pre-planned and transparent equity management by the executive.

Negatives

• A total of 5,633 shares were disposed of to cover tax withholding, which reduces the executive's immediate share count, though this is a standard practice for RSU vesting.

Risks

• The reliance on equity-based compensation means a significant portion of executive wealth is tied to the company's stock performance, exposing the executive to market fluctuations.
• Future share price volatility could impact the value of the remaining unvested RSUs and the shares held by the executive.

Future Outlook

The executive has significant unvested Restricted Stock Units with vesting schedules extending through April 2028 for existing grants and annually for four years from July 2025 for the new grant, indicating a long-term commitment to the company and future potential share accumulation.

Industry Context

This Form 4 filing reflects routine executive compensation practices within the technology sector, where equity-based awards like Restricted Stock Units are common tools for attracting, retaining, and incentivizing key personnel by aligning their interests with long-term shareholder value.

Related Party Transactions

• Shares are held indirectly by the Christopher R. Koopmans and Heather J. Koopmans Family Trust, indicating a related party ownership structure for a portion of the executive's holdings.

Stakeholder Impact

• Shareholders: The executive's increased direct and indirect ownership through RSU vesting and new grants aligns management incentives with shareholder interests, potentially fostering long-term value creation.
• Employees: The mention of shares purchased under the Employee Stock Purchase Plan (ESPP) indicates a broader employee stock ownership program, which can positively impact employee morale and retention.

Next Steps

• Continued vesting of remaining Restricted Stock Units on scheduled dates: October 15, 2025, January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028, and April 15, 2028.
• Annual vesting of the 112,560 RSU grant over four years, starting with 10% on the first anniversary of the grant date (July 15, 2025).

Key Dates

Keywords

Marvell Technology, MRVL, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Tax Withholding, 10b5-1 Plan